Endometriosis and Quality of Life Assessed by EHP 30 (NCT03981991) | Clinical Trial Compass
UnknownNot Applicable
Endometriosis and Quality of Life Assessed by EHP 30
France30 participantsStarted 2019-07-31
Plain-language summary
Assessment of the quality of life for patients suffering from isolated endometriosic lesion of utero-sacral ligaments diagnosed by MRI, before and after surgical treatment by using French version of Endometriosis Health Profile 30 (EHP 30).
This is prospective, non-controlled, non-randomized, monocentric, observational feasibility study.
Who can participate
Age range18 Years – 50 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Patient aged from 18 to 50 years
✓. Patient with medical sign proving endometriotic lesion: dysmenorrhea, deep dyspareunia or chronic pelvic pain
✓. Patient with standardized pelvic MRI realized at CHUGA
✓. Patient with an indication for laparoscopic surgical treatment
✓. Patient available to complete the questionnaire based on EHP 30
✓. Patient available for a follow-up of 6 months
✓. Patient able to understand and read French language
✓. Patient affiliated to a social security system or beneficiary of the same.
Exclusion criteria
✕. Patient with functional urinary or digestive signs related to endometriotic lesion
✕. Patient with another deep lesion proved by MRI: endometrioma, rectovaginal septum, recto-sigmoid, urinary bladder, ureters, recto-uterine pouch.
✕. Virgin patient
✕. Patient with a contraindication to MRI
✕. History of extensive pelvic surgery related to endometriosis
✕. Pregnancy
What they're measuring
1
Assess the quality of life of patients before and 3 months after laparoscopic treatment of isolated endometriosic lesions of uterosacral ligaments by French version of the EHP 30 questionnaire.